DV
Dividend Vision

GMAB — Genmab A/S

Genmab A/S (GMAB)

Total return is 746.8% over the past 17.2 years, 268.3 points behind SPY at 1015.1%. Its deepest 1-year drawdown was 32.5%.

GMAB is a single-stock equity holding representing shares in Genmab A/S, a Danish biotechnology company. The stock does not currently pay dividends, as reflected in its N/A distribution rate and lack of regular distribution frequency. This holding appeals primarily to growth-oriented investors seeking exposure to the biopharmaceutical sector rather than income-focused dividend investors.

GMAB key facts

Asset type
Stock
Asset class
Equity
Inception date
06/01/2009
Distribution frequency
None
Last close
$31.94
Market cap
$19,915,630,592
Average volume
3424900.0
Beta
0.685
Payout ratio
0.0
P/E ratio
25.1496
Forward P/E
17.9856
EPS
$1.27